BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Cervical cancer AND GATA3, HDR, 2625, ENSG00000107485, MGC5445, MGC5199, MGC2346 AND Clinical Outcome
14 results:

  • 1. Image-Guided Brachytherapy a Comparison Between 192Ir and 60Co Sources in Carcinoma Uterine Cervix.
    Sinnatamby M; Kandasamy S; Karunanidhi G; Neelakandan V; Ramapandian S; Kannan M; Sampath E
    Gulf J Oncolog; 2022 Jan; 1(38):7-14. PubMed ID: 35156639
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Downregulation of CCL22 and mutated NOTCH1 in tongue and mouth floor squamous cell carcinoma results in decreased Th2 cell recruitment and expression, predicting poor clinical outcome.
    Li X; Liu Z; Zhou W; Liu X; Cao W
    BMC Cancer; 2021 Aug; 21(1):922. PubMed ID: 34391381
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Long-term clinical outcome and dosimetric comparison of tandem and ring versus tandem and ovoids intracavitary application in cervical cancer.
    Atasever Akkas E; Altundag MB
    J BUON; 2021; 26(3):698-706. PubMed ID: 34268923
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Treatment outcome of the Combination Therapy of High-dose rate Intracavitary Brachytherapy and Intensity-modulated Radiation Therapy With Central-shielding for cervical cancer.
    Mukai Y; Minagawa Y; Inoue H; Sato A; Matsui K; Fukuda T; Onuma K; Hongo H; Shirata R; Nagata H; Hashimoto H; Inoue T; Hata M; Omura M
    In Vivo; 2020; 34(6):3387-3398. PubMed ID: 33144446
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. CT based three dimensional dose-volume evaluations for high-dose rate intracavitary brachytherapy for cervical cancer.
    Murakami N; Kasamatsu T; Wakita A; Nakamura S; Okamoto H; Inaba K; Morota M; Ito Y; Sumi M; Itami J
    BMC Cancer; 2014 Jun; 14():447. PubMed ID: 24938757
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. clinical outcome of protocol based image (MRI) guided adaptive brachytherapy combined with 3D conformal radiotherapy with or without chemotherapy in patients with locally advanced cervical cancer.
    Pötter R; Georg P; Dimopoulos JC; Grimm M; Berger D; Nesvacil N; Georg D; Schmid MP; Reinthaller A; Sturdza A; Kirisits C
    Radiother Oncol; 2011 Jul; 100(1):116-23. PubMed ID: 21821305
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Dosimetric analysis of 3D image-guided hdr brachytherapy planning for the treatment of cervical cancer: is point A-based dose prescription still valid in image-guided brachytherapy?
    Kim H; Beriwal S; Houser C; Huq MS
    Med Dosim; 2011; 36(2):166-70. PubMed ID: 20488690
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Low-dose-rate vs. high-dose-rate intracavitary brachytherapy for carcinoma of the cervix: The University of Alabama at Birmingham (UAB) experience.
    Falkenberg E; Kim RY; Meleth S; De Los Santos J; Spencer S
    Brachytherapy; 2006; 5(1):49-55. PubMed ID: 16563997
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Surgically (laparotomy/laparoscopy) guided placement of high dose rate interstitial irradiation catheters (LG-hdrT): technique and outcome.
    Orr JW; Dosoretz DD; Mahoney D; Roland PY; Kelly FJ; Blitzer P; Nakfoor B; Katin M; Rubenstein J; Boothby RR
    Gynecol Oncol; 2006 Jan; 100(1):145-8. PubMed ID: 16249021
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. High-dose versus low-dose rate brachytherapy in definitive radiotherapy of cervical cancer.
    Kucera H; Pötter R; Knocke TH; Baldass M; Kucera E
    Wien Klin Wochenschr; 2001 Jan; 113(1-2):58-62. PubMed ID: 11233470
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. The American Brachytherapy Society recommendations for high-dose-rate brachytherapy for carcinoma of the cervix.
    Nag S; Erickson B; Thomadsen B; Orton C; Demanes JD; Petereit D
    Int J Radiat Oncol Biol Phys; 2000 Aug; 48(1):201-11. PubMed ID: 10924990
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. A simple method of obtaining equivalent doses for use in hdr brachytherapy.
    Nag S; Gupta N
    Int J Radiat Oncol Biol Phys; 2000 Jan; 46(2):507-13. PubMed ID: 10661360
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. High-dose-rate versus low-dose-rate brachytherapy in the treatment of cervical cancer: analysis of tumor recurrence--the University of Wisconsin experience.
    Petereit DG; Sarkaria JN; Potter DM; Schink JC
    Int J Radiat Oncol Biol Phys; 1999 Dec; 45(5):1267-74. PubMed ID: 10613322
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. High dose rate transperineal interstitial brachytherapy for cervical cancer: high pelvic control and low complication rates.
    Demanes DJ; Rodriguez RR; Bendre DD; Ewing TL
    Int J Radiat Oncol Biol Phys; 1999 Aug; 45(1):105-12. PubMed ID: 10477013
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.